Showing results (11-20 of 5,047) with videos related to
Sort By:
Pageof 505
Pharmaceutical Research|February 1, 1991
Computer-aided dosage form design. III. Feasibility assessment for an oral prolonged-release phenytoin productJ R Irvin, R E NotariJournal of Pharmaceutical Sciences|February 7, 1998
A kinetic oxymoron: concentration-dependent first-order rate constants for hydrolysis of ceftazidimeJ O Fubara, R E NotariDrug Intelligence & Clinical Pharmacy|December 1, 1988
Predicting caffeine plasma concentrations resulting from consumption of food or beverages: a simple method and its originR W Pfeifer, R E NotariPharmaceutical Research|August 1, 1987
Computer-aided dosage form design. I. Methods for defining a long-acting first-order delivery system of maximum formulating flexibilityT Y Lee, R E NotariPharmaceutical Research|October 1, 1987
Computer-aided dosage form design. II. Methods for defining a zero-order sustained-release delivery system of maximum formulating flexibilityT Y Lee, R E NotariJournal of Pharmaceutical Sciences|June 1, 1984
Pharmacokinetic prodrug modeling: in vitro and in vivo kinetics and mechanisms of ancitabine bioconversion to cytarabineL E Kirsch, R E NotariJournal of Pharmaceutical Sciences|December 1, 1982
Drug stability in liposomal suspensions: hydrolysis of indomethacin, cyclocytidine, and p-nitrophenyl acetateJ B D'Silva, R E NotariJournal of Pharmaceutical Sciences|July 1, 1984
Aqueous conversion kinetics and mechanisms of ancitabine, a prodrug of the antileukemic agent cytarabineL E Kirsch, R E NotariJournal of Pharmaceutical Sciences|April 3, 1999
Influence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutionsJ O Fubara, R E NotariPharmaceutical Development and Technology|August 6, 1999
A nomogram to evaluate intrinsic absorption rate constants of potential oral prolonged-release candidatesS C Dyar, R E NotariPageof 505